Kleber, C J <br/><br/>
Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy.  [electronic resource] 

 -  European journal of pediatrics  Jun 2012 
 - 941-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-1076 
<br/><br/><label>Standard No.: </label>10.1007/s00431-011-1660-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--therapeutic use<br/>Age Factors<br/>Biomarkers--urine<br/>Case-Control Studies<br/>Drug Administration Schedule<br/>Female<br/>Hemangioma--drug therapy<br/>Humans<br/>Infant<br/>Male<br/>Matrix Metalloproteinase 2--urine<br/>Matrix Metalloproteinase 9--urine<br/>Propranolol--therapeutic use<br/>Treatment Outcome